Edwards Lifesciences Corp (EW) is a Healthcare · Medical Devices company listed on NYSE. Price $88.26 (+0.01%), Market cap $47.91B, P/E ratio 44.73, 52-week low–high $72.65 ~ $87.18.
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pr
Financial statements, price targets, institutional (13F) holdings and related news for Edwards Lifesciences Corp are updated in real time on BlackAll Trade.
Edwards Lifesciences Corp trades at $88.26 (+0.01%). Real-time quotes and charts are available on BlackAll Trade.
Edwards Lifesciences Corp has a market cap of about $47.91B. Its P/E ratio is 44.73.
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart va